Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4067020
Max Phase: Preclinical
Molecular Formula: C28H26ClFN4O6
Molecular Weight: 568.99
Molecule Type: Small molecule
Associated Items:
ID: ALA4067020
Max Phase: Preclinical
Molecular Formula: C28H26ClFN4O6
Molecular Weight: 568.99
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: O=C1c2c(c3n(c(=O)c2O)C2(CCC4CC42)N(CCN2C(=O)CCC2=O)C3=O)CCN1Cc1ccc(F)c(Cl)c1
Standard InChI: InChI=1S/C28H26ClFN4O6/c29-18-11-14(1-2-19(18)30)13-31-8-6-16-22(25(31)38)24(37)27(40)34-23(16)26(39)33(28(34)7-5-15-12-17(15)28)10-9-32-20(35)3-4-21(32)36/h1-2,11,15,17,37H,3-10,12-13H2
Standard InChI Key: FZIARXBYDXZUIQ-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 568.99 | Molecular Weight (Monoisotopic): 568.1525 | AlogP: 2.23 | #Rotatable Bonds: 5 |
Polar Surface Area: 120.23 | Molecular Species: NEUTRAL | HBA: 7 | HBD: 1 |
#RO5 Violations: 1 | HBA (Lipinski): 10 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 1 |
CX Acidic pKa: 8.02 | CX Basic pKa: 0.44 | CX LogP: 0.72 | CX LogD: 0.63 |
Aromatic Rings: 2 | Heavy Atoms: 40 | QED Weighted: 0.55 | Np Likeness Score: -0.52 |
1. Schreier JD, Embrey MW, Raheem IT, Barbe G, Campeau LC, Dubost D, McCabe Dunn J, Grobler J, Hartingh TJ, Hazuda DJ, Klein D, Miller MD, Moore KP, Nguyen N, Pajkovic N, Powell DA, Rada V, Sanders JM, Sisko J, Steele TG, Wai J, Walji A, Xu M, Coleman PJ.. (2017) Discovery and optimization of 2-pyridinone aminal integrase strand transfer inhibitors for the treatment of HIV., 27 (9): [PMID:28285916] [10.1016/j.bmcl.2017.02.039] |
Source(1):